Episode 207: In this screen-share, Adam Gefvert, the head analyst from White Diamond Reseach goes over the latest part of a series of short reports unveiling the many problems of Veru Pharma. [NASDAQ: VERU]
Full Short Report: https://whitediamondresearch.com/research/part-2-new-red-flags-emerge-from-verus-phase-3-covid-trial-suggesting-an-fda-rejection-is-likely/
Social media
David Capablanca
Twitter: reverse_long
Instagram: reverselong
Cobra Trading Click the link and get 33% off commissions for life as well as one month of free DAS Trader Platform
EdgeToTrade Use coupon code FRIENDLYBEAR15 for 15% off EdgeToTrade, the financial research platform for traders.
Dilution Tracker Click the link and get 10% off of Dilution Tracker
TraderSync Use coupon code FRNLYBR for 15% off monthly, 55% off yearly for TraderSync trading journal software
TradeIdeas Use coupon code FRIENDLYBEAR for 15% off TradeIdeas real-time data stock scanner
FlashSEC Click the link and get 15% off 12 months of FlashSEC
Disclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.
Support the show